5 Einträge gefunden

1. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

   1. Müller, Juliane
   2. Ehlers, Arne
   3. Burkhardt, Lia
   4. Sirma, Hüseyin
   5. Steuber, Thomas
   6. Graefen, Markus
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
2. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

   1. Krohn, Antje
   2. Seidel, Annemarie
   3. Burkhardt, Lia
   4. Bachmann, Frederik
   5. Mader, Malte
   6. Grupp, Katharina
   7. Eichenauer, Till

   2013 - Forschungsinformationssystem des UKE
3. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

   1. Krohn, Antje
   2. Seidel, Annemarie
   3. Burkhardt, Lia
   4. Bachmann, Frederic
   5. Mader, Malte
   6. Grupp, Katharina
   7. Eichenauer, Till

   2013 - Forschungsinformationssystem der UHH
4. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

   1. Stumm, Laura
   2. Burkhardt, Lia
   3. Steurer, Stefan
   4. Simon, Ronald
   5. Adam, Meike
   6. Becker, Andreas
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
5. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer

   1. Burkhardt, Lia
   2. Fuchs, Sarah
   3. Krohn, Antje
   4. Masser, Sawinee
   5. Mader, Malte
   6. Kluth, Martina
   7. Bachmann, Frederik

   2013 - Forschungsinformationssystem des UKE